-
MedPharm Opens New Manufacturing Facility
contractpharma
June 02, 2021
State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.
-
August Bioservices Expands U.S. Biopharma Manufacturing Capabilities
contractpharma
May 28, 2021
August Bioservices, LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
-
Hovione and iBET Form Strategic Collaboration
contractpharma
May 28, 2021
Contract development and manufacturing organization (CDMO) Hovione announced it has re-joined the membership of the Instituto de Biologia Experimental e Tecnológica (iBET). In 1989, Hovione was a founding member of iBET.
-
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
prnasia
May 27, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered into an exclusive contract ...
-
Clean Biologics buys CDMO Biodextris
cphi-online
May 27, 2021
Transaction enables ArchiMed-backed biopharmaceutical services group to establish North American presence and expand activities with complementary services
-
Tergus Pharma Opens New HQ & Commercial Manufacturing Facility
contractpharma
May 26, 2021
Tergus Pharma, a topical contract development and manufacturing organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
-
CDMO sector are the big winner of the pandemic, state experts
europeanpharmaceuticalreview
May 25, 2021
In a presentation, experts revealed that contract services gained significantly through pandemic contracts but cautioned that capacity shortages could continue.
-
Recro Pharma, Astex Enter Drug Development Alliance
contractpharma
May 19, 2021
Recro Pharma, Inc., a CDMO providing services for complex formulation and manufacturing challenges for oral solid dose drug products, has signed a new development agreement with Astex Pharmaceuticals, Inc.
-
Mycenax becomes Taiwan, China's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System
prnasia
May 18, 2021
Mycenax becomes one of the first CDMO companies in Asia to adapt the Beacon Optofluidic system to cell line development services.
-
Charles River to Acquire Vigene Biosciences
contractpharma
May 18, 2021
Charles River Laboratories International Inc. has signed a definitive agreement to acquire Vigene Biosciences Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene ...